美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
69339-184-03	69339-184	HUMAN PRESCRIPTION DRUG	Risperidone	Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014	N/A	ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	2 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-184-03)
69339-181-03	69339-181	HUMAN PRESCRIPTION DRUG	Risperidone	Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014	N/A	ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	.25 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-181-03)
69339-185-03	69339-185	HUMAN PRESCRIPTION DRUG	Risperidone	Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014	N/A	ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	3 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-185-03)
69339-183-03	69339-183	HUMAN PRESCRIPTION DRUG	Risperidone	Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014	N/A	ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	1 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-183-03)
69339-182-03	69339-182	HUMAN PRESCRIPTION DRUG	Risperidone	Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014	N/A	ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	.5 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-182-03)
69339-186-03	69339-186	HUMAN PRESCRIPTION DRUG	Risperidone	Risperidone	TABLET, ORALLY DISINTEGRATING	ORAL	20231014	N/A	ANDA	ANDA091537	Natco Pharma USA LLC	RISPERIDONE	4 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (69339-186-03)